Liang Zhu

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Renal Cell Carcinoma

Cell Proliferation

Histone Deacetylase

Top Venues

Journal of experimental & clinical cancer research : CR

Cancer research

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Yan Sun, Liang Zhu, Pian Liu, Huan Zhang, Feng Guo, Xin Jin
ZDHHC2-mediated AGK palmitoylation activates AKT/mTOR signaling to reduce sunitinib sensitivity in renal cell carcinoma. Cancer research (2023)
Wentao Liu, Bin Zhang, Dan Zhang, Feng Guo, Kun Ye, Liang Zhu, Xin Jin
The RBPJ/DAPK3/UBE3A signaling axis induces PBRM1 degradation to modulate the sensitivity of renal cell carcinoma to CDK4/6 inhibitors. Cell death & disease 13 (4) (2022)
Wei Li, Kun Ye, Xurui Li, Xinlin Liu, Mou Peng, Fang Chen, Wei Xiong, Yinhuai Wang, Liang Zhu
YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway. Journal of experimental & clinical cancer research : CR 41 (1) (2022)